Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit

Cancer

Volumn 112, Issue 10, 2008, Pages 2233-2240

  Thakkar, Snehal G ^a   Fu, Alex Z ^a   Sweetenham, John W ^a   Mciver, Zachariah A ^b   Mohan, Sanjay R ^b   Ramsingh, Giridharan ^b   Advani, Anjali S ^a   Sobecks, Ronald ^a   Rybicki, Lisa ^a   Kalaycio, Matt ^a   Sekeres, Mikkael A ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acute leukemia; Intensive care unit admission; Survival

Indexed keywords

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; APACHE; ARTICLE; ASSISTED VENTILATION; BIOASSAY; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW TRANSPLANTATION; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 43049106454     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23394     Document Type: Article

References (35)

1. Byrd JC, Mrozek A, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002;100:1325-4336.
2. Baudard M. Beauchamp-Nicoud A, Delmer A, et al. Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over a 16-year period. Leukemia. 1999;13:1481-1490.
3. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166-178.
4. Stone RM, Berg DT, George SL, et al. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. N Engl J Med. 1995;332:1671-167.
5. Goldstone AH, Burnett AK, Wheatley K, et al. Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AMLH trial. Blood. 2001;98:1302-1311.
6. Larson RA, Dodge RK, Linker CA, et al. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood. 1998;92:1556-1564.
7. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-180.
8. Sekeres MA, Stone RM, Zahrieb D, et al. Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome. Leukemia. 2004;18:809-816.
9. Rowe JM, Neuberg D, Friedenberg W, et al. A phase 3 study of 3 induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group. Blood. 2004;103:479-485.
10. Maver RJ. Two steps forward in the treatment of colorectal cancer. N Engl J Med. 2004;350:2406-248.
11. Hoelzer D, Thiel E, Loffler H, et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood. 1988;71:123-131.
12. Darmon M, Thiery G, Ciroldi M, et al. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med. 2005;33:2480-2493.
13. Brunet E, Lanore JJ, Dhainaut JE, et al. Is intensive care justified for patients with haematological malignancies? Intensive Care Med. 1990;16:291-297.
14. Carlon GC. Admitting patients with cancer to the intensive care unit. Crit Care Clin. 1988;4:183-191.
15. Schuster D, Marion JM. Precedents for meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematologic malignancy. Am J Med. 1983;75:402-403.
16. Rubenfeld GD, Crawford SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med. 1996;125:625-638.
17. Guidelines for intensive care unit admission, discharge, and triage. Task force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med. 1999;27:633-638.
18. Consensus statement on the triage of critically ill patients. Society of Critical Care Medicine Ethics Committee. JAMA. 1994;271:1200-1203.
19. Lemeshow S, Teres D, Klar J, et al. Mortality probability models (MPM II) based on an international cohort of intensive care unit patients. JAMA. 1993;270:2478-2486.
20. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619-1636.
21. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
22. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol. 1999;111(1 Suppl 1):S8-12.
23. Siro CA, Bastos PG, Knaus WA, Wagner DP. APACHE II scores in the prediction of multiple organ failure syndrome. Arch Surg. 1991;126:528-529.
24. Giacomini M, Cook D, DeJean D, Shaw R, Gedge E. Decision tools for life support: a review and policy analysis. Crit Care Med. 2006;34:864-870.
25. Tremblay IN, Hyland RH, Schonten BD, Hanley PJ. Survival of acute myelogenous leukemia patients requiring intubation/ventilatory support. Clin Invest Med. 1995;18:19-24.
26. Epner DE, White P, Krasnoff M, et al. Outcome of mechanical ventilation for adults with hematologic malignancy. J Investig Med. 1996;44:254-260.
27. Thiery G, Azoulay E, Darmon M, et al. Outcome of patients with cancer considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol. 2005;28:4406-4413.
28. Rabbat A, Chaoui D, Montani D, et al. Prognosis of patients with acute myeloid leukaemia admitted to intensive care. Br J Haematol. 2005;129:350-357.
29. Aggarwal A, Ong JP, Younossi ZM, et al. Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest. 2001;119:1489-1497.
30. Gildea TR, Cook WC, Nelson DR, et al. Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU. Chest. 2004;126:1598-1603.
31. Wetzler M, Dodge RK, Mrozek K, et al. Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Blood. 1999;93:3983-3993.
32. Bellamy E, Oye RK. Admitting elderly patients to the ICU: dilemmas and solutions. Geriatrics. 1987;12:61-63, 67-68.
33. Rabe C, Mey U, Paashaus M, et al. Outcome of patients with acute myeloid leukemia and pulmonary infiltrates requiring invasive mechanical ventilation-a retrospective analysis. J Crit Care. 2004;19:29-35.
34. Azoulay E, Alberti C, Bornstain C, et al. Improved survival in patients with cancer requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit J Care Med. 2001;29:519-525.
35. Sehapira DV, Studnicki J, Bradham DD, Wolff P, Jarrett A. Intensive care, survival, and expense of treating critically ill patients with cancer. JAMA. 1993;269:783-786.